InsiderTrades

Form 4 for ALKS Alkermes plc.

Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-22 · accession 0001127602-24-006562 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-23 2024-02-22 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off F - Tax $28.91 -5,452 105.4K -5% -$157.6K
D 2024-02-23 2024-02-22 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — +12.3K 110.9K +12% —
D 2024-02-23 2024-02-22 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx — -12.3K 12.3K -50% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2024-02-22 F D 5,452 $28.91 105,434 D — —
2 Common Ordinary Shares 2024-02-22 M A 12,278 — 110,886 D — — (F1) Each restricted stock unit represents a contingent right to receive one ordinary share.
3 Derivative Restricted Stock Unit Award 2024-02-22 M D 12,278 — 12,279 D — · — to — 12,278 Ordinary Shares (F1) Each restricted stock unit represents a contingent right to receive one ordinary share. (F2) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/22/2022.